I am a physician-scientist. I underwent medical school training and embarked on an integrated five-year general and vascular surgery residency program followed by a clinical fellowship in Pediatric and Vascular Surgery focusing on cardiovascular complications and hemodialysis access in patients with end-stage kidney disease. In doing so, I developed a deep appreciation of the impact of vascular morbidities on overall disease burden. During my clinical training, I performed epidemiological research in an interdisciplinary setup as a country lead with a group in King’s College, UK. However, I was not exposed to the power of translational research. Upon joining the lab of Dr. Chitalia at the Boston University School of Medicine, I was exposed to how to bring clinically relevant problems to testing them bench and dissect mechanistically. With my clinical experience in vascular medicine, oncosurgery, and research experience in thrombosis, I was granted an AHA SFRN fellowship on cardio-oncology. I have developed various animal models, such as different models of femoral artery ligation for hind limb ischemia and inferior vena cava ligation assays in mice as a model of deep vein thrombosis. My passion is to understand molecular pathobiology driving such fundamental processes and amalgamate the clinical experience with translational science focusing on cardiometabolic risk factors.